An outbreak of respiratory syncytial virus infection in a bone marrow transplant unit: Effect on engraftment and outcome of pneumonia without specific antiviral treatment

Bone Marrow Transplantation

Volumn 32, Issue 2, 2003, Pages 195-203

  Abdallah, A ^a   Rowland, K E ^a   Schepetiuk, S K ^b   To, L B ^a,b,c   Bardy, P ^a,b  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Engraftment; Immunocompromised; Respiratory syncytial virus; RSV pneumonia; Stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IDARUBICIN; IMMUNOGLOBULIN; MELPHALAN; OXYGEN; PREDNISOLONE; RIBAVIRIN; TACROLIMUS; THALIDOMIDE;

ADULT; AGED; ALLOTRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; AUTOTRANSPLANTATION; CANCER RECURRENCE; CAUSE OF DEATH; CLINICAL ARTICLE; DISEASE SEVERITY; EPIDEMIC; FATALITY; FEVER; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HIGH RISK PATIENT; HLA MATCHING; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; IMMUNE DEFICIENCY; INFECTION CONTROL; INTENSIVE CARE UNIT; LOWER RESPIRATORY TRACT INFECTION; MULTIPLE MYELOMA; NEUTROPENIA; NEUTROPHIL; OUTCOMES RESEARCH; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; STEM CELL TRANSPLANTATION; THROMBOCYTE; UPPER RESPIRATORY TRACT INFECTION; VIRUS INFECTION; VIRUS PNEUMONIA;

ADULT; AGED; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; FEMALE; GRAFT SURVIVAL; HEMATOLOGIC DISEASES; HOSPITAL UNITS; HUMANS; IMMUNOSUPPRESSION; MALE; MIDDLE AGED; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; TREATMENT OUTCOME;

EID: 0042370067     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704116     Document Type: Article

References (32)

1. Dudas RA, Karron RA. Respiratory syncytial virus vaccines. Clin Microbiol Rev 1998; 11: 430-439.
2. Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev 2000; 13: 371-384.
3. Harrington RD, Hooton TM, Hackman RC et al. An outbreak of respiratory syncytial virus in a bone marrow transplant center. J Infect Dis 1992; 165: 987-993.
4. Englund JA, Piedra PA, Whimbey E. Prevention and treatment of respiratory syncytial virus and parainfluenza viruses in immunocompromised patients. Am J Med 1997; 102: 61-70.
5. Bowden RA. Respiratory virus infections after marrow transplant: the Fred Hutchinson Cancer Research Center experience. Am J Med 1997; 102: 27-30.
6. Ghosh S, Champlin RE, Englund J et al. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: combination therapy with aerosolized ribavirin and intravenous immunoglobulin. Bone Marrow Transplant 2000; 25: 751-755.
7. Ghosh S, Champlin RE, Ueno NT et al. Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: combination therapy with aerosolized ribavirin and parenteral immunoglobulins. Bone Marrow Transplant 2001; 28: 271-275.
8. De Vincenzo JP, Leombruno D, Soiffer RJ et al. Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1051-1056.
9. Ljungman P. Respiratory virus infections in bone marrow transplant recipients: the European perspective. Am J Med 1997; 102: 44-47.
10. Whimbey E, Couch RB, Englund JA et al. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia. Clin Infect Dis 1995; 21: 376-379.
11. Whimbey E, Champlin RE, Couch RB et al. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients. Clin Infect Dis 1996; 22: 778-782.
12. Schepetiuk SK, Kok T. The use of MDCL, MEK and LLC-MK2 cell lines with enzyme immunoassay for the isolation of influenza and parainfluenza viruses from clinical specimens. J Virol Methods 1993; 42: 241-250.
13. Kok T, Mickan LD, Burrell CJ. Routine diagnosis of seven respiratory viruses and Mycoplasma pneumoniae by enzyme immunoassay. J Virol Methods 1994; 50: 87-100.
14. McCarthy AJ, Kingman HM, Kelly C et al. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation. Bone Marrow Transplant 1999; 24: 1315-1322.
15. Brandenburg AH, van Beek R, Moll HA et al. G protein variation in respiratory syncytial virus group A does not correlate with clinical severity. J Clin Microbiol 2000; 38: 3849-3852.
16. Mazzulli T, Peret TC, McGeer A et al. Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward. J Infect Dis 1999; 180: 1686-1689.
17. Hall CB. Nosocomial respiratory syncytial virus infections: the 'cold war' has not ended. Clin Inject Dis 2000; 31: 590-596.
18. Raad I, Abbas J, Whimbey E. Infection control of nosocomial respiratory viral disease in the immunocompromised host. Am J Med 1997; 102: 48-52.
19. Jones BL, Clark S, Curran ET et al. Control of an outbreak of respiratory syncytial virus infection in immunocompromised adults. J Hosp Infect 2002; 44: 53-57.
20. Hertz MI, Englund JA, Snover D et al. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature. Medicine 1989; 68: 269-281.
21. Whimbey E, Champlin RE, Englund JA et al. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients. Bone Marrow Transplant 1995; 6: 393-399.
22. Lewinsohn DM, Bowden RA, Mattson D et al. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob Agents Chemother 1996; 40: 2555-2557.
23. Englund JA, Sullivan CJ, Jordan MC et al. Respiratory syncytial virus infection in immunocompromised adults. Ann Intern Med 1988; 109: 203-208.
24. Fouillard L, Mouthon L, Laporte JP et al. Severe respiratory syncytial virus pneumonia after autologous bone marrow transplantation: a report of three cases and review. Bone Marrow Transplant 1992; 2: 97-100.
25. Ljungman P, Ward KN, Crooks BN et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479-484.
26. To LB, Haylock DN, Simmons PJ et al. The biology and clinical uses of blood stem cells. Blood 1997; 89: 2233-2258.
27. Craddock C, Bardy P, Kreiter S et al. Engraftment of T-cell-depleted allogeneic haematopoietic stem cells using a reduced intensity conditioning regimen. Br J Haematol 2000; 111: 797-800.
28. Chakraverty R, Peggs K, Chopra R et al. Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. Blood 2002; 99: 1071-1078.
29. Gorner M, Kordelas L, Thalheimer M et al. Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine. Bone Marrow Transplant 2002; 29: 621-624.
30. Sheeran P, Jafri H, Carubelli C et al. Elevated cytokine concentrations in the nasopharyngeal and tracheal secretions of children with respiratory syncytial virus disease. Pediatr Inject Dis J 1999; 18: 115-122.
31. Gershwin LJ, Gunther RA, Anderson ML et al. Bovine respiratory syncytial virus-specific IgE is associated with interleukin-2 and -4, and interferon-gamma expression in pulmonary lymph of experimentally infected calves. Am J Vet Res 2000; 61: 291-298.
32. Chang J, Braciale TJ. Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract. Nat Med 2002; 8: 54-60.